This company has shut down. 9 Meters Biopharma is no longer operating — its last tracked round was a Post-IPO Equity in 2023.
Explore the Startup Graveyard9 Meters Biopharma is a gastrointestinal platform company focusing on patients with rare disorders and unmet needs.
9 Meters Biopharma has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2023.
9 Meters Biopharma is headquartered in Raleigh, United States.
9 Meters Biopharma is a gastrointestinal platform company focusing on patients with rare disorders and unmet needs.
9 Meters Biopharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"9 Meters Biopharma — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/9-meters-biopharma. Accessed August 14, 2026.
VCBacked. (2023). 9 Meters Biopharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/9-meters-biopharma
{{cite web |title=9 Meters Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/9-meters-biopharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated